Russian Prime Minister Mikhail Mizustin announced that Russia was registered. The third COVID-19 vaccine, CoviVac, was developed by the Schumakov Federal Science Center in Moscow. For domestic use
Russia registered Two COVID-19 vaccines, Sputnik V and EpiVacCorona, for the third vaccine have not yet been completed in Phase III trials.
Sputnik V vaccine developed by Kamaleya Research Institute Has been registered in August last year. And the final trial begins in September. Then it was injected in December. After preliminary results, the vaccine was 91.4% effective. So far, more than 2 million Russians have received at least the first dose of the Sputnik V vaccine.
The second vaccine was developed by the Vector Institute. About to start being released The prime minister says Russia is the only country with three COVID-19 vaccines.
The Schumakov Federal Science Center It developed the third vaccine, founded in 1955 by Mikhail Shumakov, who worked with Albert Sabin, American scientist. During the cold war Which led to the production of polio vaccine
The CoviVac vaccine is a whole virus vaccine that has either killed (whole virion) or weakened and not caused disease, while the Sputnik V vaccine is a two-type adrenovirus vaccine for EpiVacCorona. That is extracted from the virus to stimulate the immune system
Alexander Schepernov, virologist Given that the advantage is that CoviVac contains a whole virus component. Causing a wide range of immunity Likely to protect against new species Mutated
The Deputy Prime Minister of Russia said CoviVac had to be injected two doses 14 days apart, able to be transported and stored at a normal refrigerator temperature of 2-8 degrees Celsius. Russia will produce 88 million doses of the vaccine in the first half of this year. Of these, 83 million doses of Sputnik V vaccine.
News reports say the Sputnik V is approved for use under emergencies in many countries. San Marino is the 30th country to approve the vaccine.
—
